Financial Assurances. As of the date hereof and as of the Closing Date, the Investor has and will have access to cash in an amount sufficient to pay to the Company the Aggregate Purchase Price.
Appears in 12 contracts
Sources: Share Purchase Agreement (Generation Bio Co.), Stock Purchase Agreement (Entrada Therapeutics, Inc.), Share Purchase Agreement (Wave Life Sciences Ltd.)
Financial Assurances. As of the date hereof Signing Date, the Investor has, and as of the Closing Date, the Investor has and will have have, access to cash in an amount sufficient to pay to the Company the Aggregate Purchase Price.
Appears in 7 contracts
Sources: Subscription Agreement (Biohaven Pharmaceutical Holding Co Ltd.), Stock Purchase Agreement (Arvinas, Inc.), Stock Purchase Agreement (Neurocrine Biosciences Inc)
Financial Assurances. As of the date hereof of this Agreement and as of the Closing Date, the Investor has and will have access to cash in an amount sufficient to pay to the Company the Aggregate Purchase Price.
Appears in 5 contracts
Sources: Securities Purchase Agreement (Duggan Robert W), Securities Purchase Agreement (Summit Therapeutics Inc.), Securities Purchase Agreement (Summit Therapeutics Inc.)
Financial Assurances. As of the date hereof and as of the Closing Datehereof, the Investor has and will have access to cash in an amount sufficient to pay to the Company the Aggregate Purchase Price.
Appears in 2 contracts
Sources: Stock Purchase Agreement (C4 Therapeutics, Inc.), Share Purchase Agreement (Scholar Rock Holding Corp)
Financial Assurances. As of the date hereof Signing Date, the Investor has, and as of the Closing Date, the Investor has and will have have, access to cash in an amount sufficient to pay to the Company the Aggregate Purchase Price.. 5.12
Appears in 1 contract
Sources: Collaboration and License Agreement (Neurocrine Biosciences Inc)
Financial Assurances. As of the date hereof of this Agreement and as of the Closing Date, the Investor has and will have access to cash in an amount sufficient to pay to the Company the Aggregate Purchase PriceConsideration.
Appears in 1 contract
Sources: Securities Purchase Agreement (Summit Therapeutics Inc.)
Financial Assurances. As of the date hereof and as of the Closing Date, the Investor has and will have access to cash in an amount sufficient to pay to the Company the Aggregate Purchase Price.
Appears in 1 contract
Financial Assurances. As of the date hereof and as of the Closing Date, the Investor Purchaser has and will have access to cash in an amount sufficient to pay to the Company the Aggregate Purchase Price.
Appears in 1 contract
Sources: Stock Purchase Agreement (SpringWorks Therapeutics, Inc.)